-
Karen H. Lu, MD,
MD Anderson Cancer Center
Early Career Investigator Grant
Understanding the Molecular Differences in Histologic Grades of Ovarian Cancer: Implications for Discovering New Prognostic Markers
-
Gary Yiu, PhD,
Brigham and Women’s Hospital, Dana Farber Cancer Institute
Individual Investigator Award
Molecular Classification of Epithelial Ovarian Tumors
-
Xiang-Xi Xu, PhD,
Fox Chase Cancer Center
Individual Investigator Award
Studying the Role of a Novel Protein, Dab2, in Ovarian Cancer
-
Christos Patriotis, PhD,
Fox Chase Cancer Center
Early Career Investigator Grant
Molecular Genetic Mechanisms of Ovarian Oncogenesis
-
Iman Osman, MD,
University of New Mexico
Individual Investigator Award
Hypoxia Inducible Factor-1 alpha (HIF-1): A Potential New Prognostic Marker for Advanced Ovarian Cancer and Target of Treatment
-
William Irvin, MD,
University of Virginia Medical Center
Individual Investigator Award
Vaccine Trial for Ovarian Cancer
-
Wei Hu, MD, PhD,
MD Anderson Cancer Center
Individual Investigator Award
Effects of a Novel Combination Drug Treatment on Cell Lines Derived from Human Ovarian Cancer
-
Robin Farias-Eisner, MD, PhD,
UCLA School of Medicine
Early Career Investigator Grant
O-glycosylation: a Molecular Mechanism for Transciptional Regulation, Cellular Transformation and Nitric Oxide (NO) Mediated Tumoricidal Activity